Deferoxamine mesylate 2 g / 1 Injection 4 Injection, Powder, Lyophilized, For Solution

Reference details for licensed healthcare facility review and verification.

Deferoxamine mesylate NDC Family 60505-6237 Deferoxamine mesylate 2 g / 1

NDC 11	60505-6237-06
Product NDC	60505-6237
Generic Drug Name	Deferoxamine mesylate
Brand Name	Deferoxamine mesylate
Manufacturer	Apotex Corp.
Strength	2 g / 1
Dosage Form	Injection
Drug Type	Intramuscular; Intravenous
Package Quantity	4 Injection, Powder, Lyophilized, For Solution
Package Description	4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (60505-6237-6)
Active Ingredients	Deferoxamine Mesylate
Marketing Category	ANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Deferoxamine mesylate 2 g / 1 Injection is tracked under NDC 60505-6237-06 and rolls up into product family 60505-6237. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 4 Injection, Powder, Lyophilized, For Solution.
Manufacturer: Apotex Corp..
Dosage form: Injection.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this product reference.

Review the generic familyDeferoxamine mesylate

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Potential alternatives with matching presentation

Open the comparison hub or review package-level listings from 2 product-NDC families with matching normalized presentation details. Review each product detail page before treating any item as a true alternative.

View Potential Alternative HubDeferoxamine mesylate 2 g / 1 Injection 4 Injection, Powder, Lyophilized, For Solution Injection Powder Lyophilized Solution2 package-level listings in the comparison hub.

Sample package-level pages in this comparison set

Deferoxamine mesylate 2 g / 1 Injection 4 Injection, Powder, Lyophilized, For SolutionNDC 68083-0173-01 | 4 Injection, Powder, Lyophilized, For Solution | Gland Pharma Limited

Deferoxamine mesylate 2 g / 1 Injection 4 Injection, Powder, Lyophilized, For Solution, NDC 60505-6237-06, is a Apotex Corp. 2 g / 1 injection presentation packaged as 4 Injection, Powder, Lyophilized, For Solution.

NDC search formats

Canonical NDC 11: 60505-6237-06
Digits-only NDC 11: 60505623706
Possible 10-digit display format: 60505-6237-6 (6050562376)

Helpful product links

Search by brand name: Deferoxamine mesylate
NDC 11: 60505-6237-06
Product family NDC: 60505-6237
VA classification code: AD300
VA classification code description: HEAVY METAL ANTAGONISTS
CMOP ID: D0601
VUID: 4016339